Cargando…
Overexpressed oncogenic tumor-self antigens: New vaccine targets
Overexpressed tumor-self antigens represent the largest group of candidate vaccine targets. Those exhibiting a role in oncogenesis may be some of the least studied but perhaps most promising. This review considers this subset of self antigens by highlighting vaccine efforts for some of the better kn...
Autores principales: | Bright, Robert K, Bright, Jennifer D, Byrne, Jennifer A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514139/ https://www.ncbi.nlm.nih.gov/pubmed/25483660 http://dx.doi.org/10.4161/hv.29475 |
Ejemplares similares
-
Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype
por: Elizondo, C. Riccay, et al.
Publicado: (2022) -
Injection site and regulatory T cells influence durable vaccine-induced tumor immunity to an over-expressed self tumor associated antigen
por: Bright, Jennifer D, et al.
Publicado: (2013) -
Oncogenic mutation or overexpression of oncogenic KRAS or BRAF is not sufficient to confer oncogene addiction
por: Ito, Reina E., et al.
Publicado: (2021) -
Oncogene-targeting nanoprobes for early imaging detection of tumor
por: Li, Wenyue, et al.
Publicado: (2023) -
Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines
por: Goyvaerts, Cleo, et al.
Publicado: (2015)